COEUS

Established in 2009, and acquired by Red Nucleus (rednucleus.com) in 2025, COEUS (1COEUS.com) is a leading market access consulting, communications, technology, and talent firm. Through its fully integrated full-service “consultagency,” COEUS provides its clients both strategic and communication services that enhance decision-making and communication between payers and emerging and established pharmaceutical manufacturers. The company offers a robust array of market access services pre-launch through post-launch, including support in medical affairs, trade and distribution, patient services, market insights, and full- and part-time personnel support. COEUS leverages the deep knowledge and experience of the company’s many subject matter experts to deliver a broad range of services across all drug types with a particular focus on gene and cell therapies, rare disease, and oncology. In its 16-year history, the company has supported the launch of more than 150 pharmaceutical brands and has worked with over 300 pharma clients including many top global pharmaceutical manufacturers.